Efficacy and safety of intra-articular steroid injection for inflamed atlantoaxial joint in patients with rheumatoid arthritis

Recruiting

• Conditions: atlantoaxial joint arthritis in rheumatoid patients; Inflammatory and Immune System - Rheumatoid arthritis

• Registration Number: ACTRN12616000750482
• Lead Sponsor: Diab Fuad Hetta

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic steroid administration

Exclusion Criteria

Coagulopathy, allergy to contrast material, pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Resolution of MRI findings of inflammation of AAJ[after 3 month from the procedure];Neck pain intensity assessed by VAS score reported by rheumatologist, on behalf of the participants. [every 2 weeks for 3 month following injection procedure.]

Secondary Outcome Measures

Name	Time	Method
eck mobility assessed by rheumatologist using Oswestry cervical pain quetionnaire[every 2 weeks for 3 month following injection procedure.];Side effects of AAJ injection procedure e.g. intrathecal or epidural spread of injectate and nerve injury assessed by the injectionist (senior pain clinitian)using fluroscopy.[during injection and immediately following the injection]